Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05725109 · ClinicalTrials.gov registry record
Hepatitis C Diagnosis to Treatment Management
A clinical trial, sponsored by Epividian.
- Completed
- Registry status
- 1,063
- Enrollment target
NCT05725109 is a clinical trial that has completed, run by Epividian. The registered enrollment target is 1,063 participants.
The verdict
NCT05725109 has completed, sponsored by Epividian.
- COMPLETED
- Registry status
- 1,063 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate whether sending alerts to healthcare providers and clinic staff to identify patients with untreated hepatitis C infection can increase the uptake of hepatitis C treatment. A period of time without alerts will be compared to a period of time with alerts.
Interventions
- OTHER Standard of Care
- OTHER Hepatitis C Treatment Alerts in CHORUS™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,063 participants |
| Start Date | 2023-01-16 |
| Est. Completion | 2023-10-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05725109
The ClinicalTrials.gov registry entry for NCT05725109 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,063 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Epividian, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT05725109 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05725109 about?
NCT05725109 is a clinical study titled "Hepatitis C Diagnosis to Treatment Management". The objective of this study is to evaluate whether sending alerts to healthcare providers and clinic staff to identify patients with untreated hepatitis C infection can increase the uptake of hepatitis C treatment. A period of time without alerts will be compared to a period of time with alerts.
What is the current status of trial NCT05725109?
This trial is currently completed. The enrollment target is 1,063 participants. The study started on 2023-01-16. Estimated completion is 2023-10-17.
What interventions are being tested in trial NCT05725109?
The interventions under investigation include: Standard of Care (OTHER), Hepatitis C Treatment Alerts in CHORUS™ (OTHER).
Who is sponsoring clinical trial NCT05725109?
This trial is sponsored by Epividian, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.